View in EDS

Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis".

Saved in:
Bibliographic Details
Title: Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis".
Authors: Rand K; Maths in Health B.V., Klimmen, The Netherlands., Gebauer K; Fremantle Dermatology, Fremantle, Australia., Binamer Y; King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Cho YT; National Taiwan University Hospital, Taipei, Taiwan., Papadimitropoulos M; Eli Lilly and Company, Indianapolis, IN, USA., Yang C; Eli Lilly and Company, Indianapolis, IN, USA., Agell H; Almirall S.A., Barcelona, Spain., Akmaz B; Almirall S.A., Barcelona, Spain., Seminario-Vidal L; Eli Lilly and Company, Indianapolis, IN, USA. seminario_vidal_lucia@lilly.com.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jun 26. Date of Electronic Publication: 2026 Jun 26.
Publication Type: Letter; Comment
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb)
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42360591
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis".
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rand+K%22">Rand K</searchLink>; Maths in Health B.V., Klimmen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gebauer+K%22">Gebauer K</searchLink>; Fremantle Dermatology, Fremantle, Australia.<br /><searchLink fieldCode="AU" term="%22Binamer+Y%22">Binamer Y</searchLink>; King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Cho+YT%22">Cho YT</searchLink>; National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Papadimitropoulos+M%22">Papadimitropoulos M</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Yang+C%22">Yang C</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Agell+H%22">Agell H</searchLink>; Almirall S.A., Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Akmaz+B%22">Akmaz B</searchLink>; Almirall S.A., Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Seminario-Vidal+L%22">Seminario-Vidal L</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA. seminario_vidal_lucia@lilly.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101590450%22">Dermatology and therapy</searchLink> [Dermatol Ther (Heidelb)] 2026 Jun 26. <i>Date of Electronic Publication: </i>2026 Jun 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare+Communications%22">Springer Healthcare Communications </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101590450 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8210 (Print) <i>NLM ISO Abbreviation: </i>Dermatol Ther (Heidelb)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42360591
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13555-026-01796-w
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis".
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rand K
      – PersonEntity:
          Name:
            NameFull: Gebauer K
      – PersonEntity:
          Name:
            NameFull: Binamer Y
      – PersonEntity:
          Name:
            NameFull: Cho YT
      – PersonEntity:
          Name:
            NameFull: Papadimitropoulos M
      – PersonEntity:
          Name:
            NameFull: Yang C
      – PersonEntity:
          Name:
            NameFull: Agell H
      – PersonEntity:
          Name:
            NameFull: Akmaz B
      – PersonEntity:
          Name:
            NameFull: Seminario-Vidal L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 06
              Text: 2026 Jun 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2193-8210
          Titles:
            – TitleFull: Dermatology and therapy
              Type: main
ResultId 1